Maroulakou et al. have reported that Akt3 gene ablation has no significant inhibitory effects on the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T (PyMT) transgenic mice [48]. The gene discussed is ERBB2; the disease is breast adenocarcinoma.